Clinical Trial Update: A Study to Evaluate 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating the investigational drug 9MW1911 for chronic obstructive pulmonary disease, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• 9MW1911

Snippet

Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd. | Conditions: Chronic Obstructive Pulmonary Disease COPD | Phase 2 | Status: RECRUITING